7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 
      
    		                                               
      cash flows from operating activities
    		                                               
      net earnings
    		22,499,000 -11,827,000 15,328,000 38,497,000 19,916,000 124,000 1,175,000 -15,976,000 -831,000 16,948,000 25,481,000 1,749,000 7,865,000 25,616,000 2,442,000 21,562,000 23,726,000 5,694,000 30,768,000 39,997,000 34,667,000 21,518,000 33,129,000 28,860,000 32,727,000 18,340,000 28,011,000 30,737,000 26,352,000                   
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                               
      depreciation and amortization
    		21,358,000 20,383,000 18,845,000 20,102,000 20,718,000 20,749,000 21,676,000 21,857,000 20,725,000 20,601,000 20,849,000 21,775,000 21,557,000 21,362,000 12,707,000 6,675,000 6,621,000 6,592,000 5,520,000 7,577,000 3,312,000 1,732,000 1,630,000 1,674,000 1,676,000 1,679,000 1,884,000 1,780,000 1,707,000 4,378,000 1,343,000 741,000 611,000 688,000 429,000 220,000 217,000 214,000 241,000 233,000 227,000 200,000 164,000 162,000 212,000 213,000 225,000 
      amortization of premium/discount on marketable securities
    		-32,000 -1,074,000 -674,000 966,000 -363,000 1,894,000 727,000 68,000 139,000 -1,056,000 18,000 2,147,000 1,428,000 -360,000 1,263,000 1,526,000 -665,000 -1,706,000 328,000 -4,201,000 1,435,000 -451,000 -1,146,000 -1,564,000     89,000                   
      change in fair value of contingent consideration
    		0 7,660,000 356,000 -1,016,000 -4,355,000 -1,095,000  -456,000 790,000 -1,647,000  486,000 743,000 665,000  80,000 -8,750,000 1,020,000                              
      realized gains from sales of marketable securities
    		  0        0 -1,000   -126,000 -2,000 -3,000 -216,000 -716,000 -320,000                            
      share-based compensation expense
    		7,507,000 8,068,000 7,632,000 7,674,000 6,552,000 5,897,000 6,445,000 7,920,000 6,088,000 6,306,000 4,261,000 4,985,000 4,297,000 4,025,000 4,036,000 4,027,000 5,476,000 4,371,000 3,121,000 4,490,000 4,962,000 3,988,000 3,623,000 3,914,000 4,022,000 3,287,000 2,597,000 3,068,000 2,635,000 2,360,000 2,260,000 1,827,000 1,483,000 1,612,000 1,359,000 1,132,000 1,119,000 901,000          
      deferred income tax benefit
    		-7,162,000 -3,990,000 -72,000 -6,467,000 -8,115,000 -5,482,000 -10,459,000 -9,266,000 -5,554,000 -435,000    -13,011,000     848,000 2,782,000 -3,600,000 538,000 -4,143,000 -2,550,000 582,000 279,000      4,258,000                
      inventory valuation write-down
    		920,000 547,000                                              
      payment of contingent consideration
    		0 -4,900,000         0 0 0 -22,900,000                                  
      other noncash adjustments
    		1,953,000 1,826,000 -756,000 1,658,000 4,174,000 2,449,000 3,435,000 2,058,000 5,968,000 2,459,000 3,655,000 9,170,000 -1,271,000 84,000 -1,398,000 629,000 551,000 -1,202,000                              
      changes in operating assets and liabilities:
    		                                               
      accounts receivable
    		4,809,000 -3,563,000 3,331,000 7,086,000 -4,760,000 -3,579,000 -2,390,000 -5,209,000 4,393,000 21,971,000 -1,408,000 -5,865,000 -12,905,000 3,812,000 -3,485,000 3,747,000 -10,200,000 13,805,000 -7,767,000 -6,409,000 11,392,000 -31,823,000 -593,000 -2,095,000 -4,574,000 23,013,000      2,642,000          -6,671,000      
      inventories
    		4,887,000 4,731,000 3,187,000 4,604,000 6,025,000 1,990,000 5,028,000 6,912,000 -3,979,000 -1,851,000 -11,554,000 -8,146,000 4,310,000 -2,468,000 -5,249,000 -1,381,000 -6,902,000 -1,048,000 -4,687,000 -7,126,000 -521,000 2,210,000 -1,124,000 520,000      1,676,000                  
      prepaid expenses and other assets
    		-2,502,000 7,372,000 -10,810,000 -1,753,000 728,000 -7,517,000 7,804,000 20,406,000 -28,203,000 -341,000 9,205,000 1,232,000 805,000 1,061,000 4,953,000 4,652,000 -17,635,000 -368,000               -929,000 1,729,000 260,000   38,000    96,000 -1,051,000 133,000    
      accrued product returns and rebates
    		10,783,000 1,428,000 -419,000 -5,995,000 7,893,000 12,952,000 -8,199,000 13,647,000 974,000 -3,813,000 -6,805,000 12,709,000 5,580,000 7,457,000 -1,354,000 -41,550,000 44,862,000 2,544,000 -10,780,000 -7,132,000 16,474,000 11,824,000 9,579,000 2,116,000                        
      accounts payable and other liabilities
    		-6,485,000 3,938,000 -418,000 -11,827,000 -12,789,000 10,019,000 -269,000 -6,086,000 -19,384,000 -10,548,000 -6,504,000 -24,422,000 41,242,000 -29,479,000 33,905,000 -10,047,000 4,329,000 -10,008,000                              
      net cash from operating activities
    		58,535,000 30,599,000 44,406,000 53,520,000 35,624,000 38,401,000 44,958,000 35,875,000 -18,874,000 49,126,000 27,564,000 13,841,000 71,119,000 4,302,000 48,763,000 -4,110,000 46,274,000 36,200,000 31,933,000 5,599,000 91,951,000 8,916,000 43,791,000 37,658,000 28,687,000 32,993,000 62,448,000 6,556,000 27,133,000 39,005,000 25,942,000 13,358,000 28,239,000   -2,983,000 14,669,000 503,000    -15,550,000      
      capex
    		-455,000 -327,000 -213,000 -200,000 -64,000 -248,000 0 -150,000 -159,000 -278,000 10,000 -147,000 0 -851,000 -40,000 0 0 -1,508,000 -215,000 -162,000 -535,000 -2,537,000 -2,029,000 -462,000 0 0 0 0 0 0 0 0 0   0 0 0    -377,000      
      free cash flows
    		58,080,000 30,272,000 44,193,000 53,320,000 35,560,000 38,153,000 44,958,000 35,725,000 -19,033,000 48,848,000 27,574,000 13,694,000 71,119,000 3,451,000 48,723,000 -4,110,000 46,274,000 34,692,000 31,718,000 5,437,000 91,416,000 6,379,000 41,762,000 37,196,000 28,687,000 32,993,000 62,448,000 6,556,000 27,133,000 39,005,000 25,942,000 13,358,000 28,239,000   -2,983,000 14,669,000 503,000    -15,927,000      
      cash flows from investing activities
    		                                               
      purchases of marketable securities
    		-140,556,000 -118,557,000 -145,405,000 -224,928,000 -123,980,000 -193,700,000     -66,325,000 -134,162,000 -108,440,000 -98,063,000 -3,939,000 -74,362,000 -114,209,000 -119,063,000 -8,000,000 -72,508,000 0 -15,382,000 -48,586,000 -96,195,000                  -17,964,000      
      maturities of marketable securities
    		110,404,000 156,201,000 132,980,000 148,117,000                                            
      acquisition of sage, net of cash acquired
    		                                               
      purchases of property and equipment
    		-455,000 -327,000 -213,000 -200,000 -64,000 -248,000  -150,000 -159,000 -278,000       0 -1,508,000 -215,000 -162,000 -535,000 -2,537,000 -2,029,000 -462,000                  -377,000      
      net cash from investing activities
    		-30,607,000 37,317,000 -12,638,000 -77,011,000 -48,594,000 -51,624,000 -65,981,000 34,634,000 60,296,000 239,780,000 -48,765,000 -82,232,000 -15,679,000 -69,987,000 76,130,000 -5,704,000 -80,894,000 -71,445,000 49,345,000 -11,302,000 -108,180,000 35,438,000 19,438,000 -8,355,000               -973,000   4,606,000      
      cash flows from financing activities
    		                                               
      proceeds from issuance of common stock
    		3,276,000 2,042,000 6,877,000 3,462,000 1,659,000 2,910,000 3,082,000 -230,000 1,947,000 1,811,000 2,829,000 6,455,000 2,273,000 866,000 1,575,000 524,000 2,749,000 2,247,000 2,815,000 77,000 1,437,000 32,000 1,263,000 242,000 1,640,000 783,000 828,000 6,646,000 2,857,000 2,346,000 1,560,000 604,000 260,000 871,000 124,000 58,000 862,000 147,000 14,000 245,000 6,000 11,000 217,000 1,936,000   49,000 
      employee taxes paid related to net share settlement of equity awards
    		-46,000 -3,341,000 -987,000 -387,000 -1,000 -1,340,000                                          
      net cash from financing activities
    		935,000 -21,399,000 5,890,000 3,075,000 1,658,000 1,570,000 1,092,000 -230,000 -478,916,000 80,174,000 2,829,000 6,455,000 2,273,000 -22,034,000 -136,740,000 1,324,000 2,749,000 2,247,000 3,069,000 -979,000 1,437,000 32,000 1,263,000 242,000 1,640,000 783,000 828,000 6,646,000 367,713,000 2,346,000 1,560,000 604,000 260,000 871,000 124,000 58,000 862,000 147,000 14,000 245,000 5,000 -18,000   -2,225,000   
      net change in cash, cash equivalents, and restricted cash
    		     -11,653,000   -437,494,000 369,080,000                                      
      cash and cash equivalents at beginning of year
    		0 69,331,000 0 0 0 75,054,000 0 0 0 93,120,000 0 0 0 203,434,000 0 0 0 288,640,000 0 0 0 181,381,000 0 0 0 192,248,000 0 0 100,304,000                   
      cash, cash equivalents, and restricted cash at end of period
    		     63,401,000    462,200,000                                      
      reconciliation of cash, cash equivalents, and restricted cash reported in the condensed consolidated balance sheets
    		                                               
      cash and cash equivalents
    		                                               
      restricted cash
    		                                               
      total cash, cash equivalents, and restricted cash shown in the statement of cash flows
    		                                               
      supplemental cash flow information
    		                                               
      cash paid for income taxes
    		12,423,000 274,000 12,911,000 19,581,000 20,426,000 336,000 9,547,000 6,621,000 20,231,000 203,000  6,015,000 8,065,000 478,000  4,415,000 20,395,000 301,000                              
      net change in cash and cash equivalents
    		28,863,000 46,517,000 37,658,000 -20,416,000   -19,931,000    -18,372,000 -61,936,000 57,713,000 -87,719,000 -11,847,000 -8,490,000 -31,871,000 -32,998,000 84,347,000 -6,682,000 -14,792,000 44,386,000 64,492,000 29,545,000     343,836,000    18,803,000         -10,962,000      
      cash and cash equivalents at end of period
    		28,863,000 115,848,000  -20,416,000    70,279,000    -61,936,000 57,713,000 115,715,000  -8,490,000 -31,871,000 255,642,000 84,347,000 -6,682,000 -14,792,000 225,767,000 64,492,000 29,545,000 -35,434,000 122,778,000 88,613,000 -408,935,000 444,140,000 20,187,000 2,138,000 59,599,000 18,149,000 16,326,000 19,830,000 -6,816,000 7,300,000 25,810,000 25,824,000 -296,000 12,252,000 -10,962,000 14,998,000 18,909,000 -23,830,000 31,376,000 15,866,000 
      cash paid for operating leases
    		 3,892,000  5,086,000 4,136,000 4,002,000 3,870,000 4,533,000 5,252,000 3,457,000 3,336,000 3,309,000 3,289,000 2,949,000 4,295,000 3,577,000 2,202,000 1,834,000                              
      noncash investing and financing activities
    		                                               
      lease assets obtained for new operating leases
    		   22,000 921,000 2,604,000  1,965,000 1,337,000 2,601,000  761,000                                    
      other income from navitor
    		          0 0 0 -12,888,000                                  
      intangible asset impairment charges
    		                                               
      amortization of deferred financing costs and debt discount
    		      0 0 0 532,000 530,000 529,000 527,000 526,000 4,464,000 4,405,000 4,345,000 4,287,000 4,230,000 4,172,000 4,118,000 4,061,000 4,007,000 3,953,000 3,900,000 3,848,000 3,745,000 3,695,000 612,000       122,000 150,000 374,000 512,000 513,000 574,000 1,183,000 804,000 83,000    
      proceeds from credit line
    		                                               
      payments on credit line
    		                                               
      payment on convertible notes
    		      0 0                                        
      cash and cash equivalents at end of year
    		                                               
      cash paid for interest on debt
    		      0 0                                        
      property and equipment additions from utilization of tenant improvement allowance
    		          0 0 31,000 549,000                                  
      noncash operating activities
    		                                               
      sales and maturities of marketable securities
    		     142,324,000 35,604,000 34,784,000 60,455,000 240,058,000 17,550,000 52,077,000 92,185,000 28,927,000 377,963,000 68,702,000 34,265,000 49,579,000 59,001,000 61,485,000 204,579,000 53,357,000 68,703,000 88,302,000 49,022,000 47,143,000 25,805,000 12,123,000 7,343,000 10,633,000 7,279,000 5,140,000 6,740,000 8,258,000 7,400,000 11,809,000 13,131,000 8,731,000 14,894,000 17,997,000 9,096,000 23,253,000 11,547,000 12,866,000 9,742,000 7,381,000 293,000 
      noncash operating and investing activities
    		                                               
      navitor investment r&d expense
    		              0 0 0 15,000,000                              
      changes in fair value of contingent consideration
    		                                               
      contingent consideration
    		          0 0 0 -2,100,000                                  
      acquisition of uswm, net of cash acquired
    		              0 0   -1,341,000 0                            
      acquisition of adamas, net of cash acquired
    		                                               
      distribution from navitor
    		                                               
      purchase of property and equipment and deferred legal fees paid
    		          10,000 -147,000   -40,000                                 
      proceeds from line of credit
    		      0 0 0 93,000,000                                      
      payments on line of credit
    		      0 0 -78,363,000 -14,637,000                                      
      proceeds from governmental loan and grant
    		              0                                 
      repayment of acquired adamas loan
    		                                               
      supplemental cash flow information:
    		                                               
      noncash investing and financing activity:
    		                                               
      contingent consideration liability related to acquisitions
    		                                               
      deferred legal fees and fixed assets included in accounts payable and accrued expenses
    		                 160,000 -139,000 -13,000 -343,000 708,000 1,337,000                         
      cash paid for interest on convertible notes
    		          0 1,258,000 0 1,258,000 629,000 629,000 0 1,258,000 0 1,258,000 0 1,258,000 0 1,258,000 0 1,258,000                      
      distribution from (investment in) navitor
    		                                               
      payments on finance lease liability
    		                  254,000                             
      income taxes paid
    		                    283,000 324,000 15,607,000 11,138,000 23,995,000 800,000 651,000 23,656,000 5,623,000                   
      lease assets and tenant receivable obtained for new operating leases
    		             27,000           14,591,000 17,136,000                      
      lease assets obtained for new finance lease
    		                                               
      deferred income tax provision
    		           -2,507,000    1,567,000 519,000 -2,565,000            1,642,000                  
      purchases of property and equipment and deferred legal fees paid
    		             -851,000                                  
      investment in navitor pharmaceuticals, inc.
    		                  0 0                            
      contingent consideration liability accrued in uswm acquisition
    		                   200,000                            
      lease assets and tenant receivable obtained for new leases
    		                 1,432,000  487,000                            
      deferred legal fees
    		                0 -453,000 -100,000 -117,000   1,350,000 0                        
      lease assets obtained for new leases
    		                                               
      proceeds from issuance of convertible notes
    		                          0 0 402,500,000                   
      convertible notes issuance financing costs
    		                                               
      proceeds from issuance of warrants
    		                          0 0 65,688,000                   
      cash paid for biscayne acquisition
    		                                               
      contingent consideration liability related to uswm acquisition
    		                                               
      noncash interest expense
    		                   1,645,000 1,504,000 1,366,000 1,444,000                         
      noncash royalty revenue
    		                   -2,402,000 -2,351,000 -1,567,000 -1,899,000                         
      noncash operating lease cost
    		                   757,000 851,000 991,000 966,000                         
      prepaid expenses and other current assets
    		                   -4,551,000 -4,313,000 -454,000 1,513,000 -655,000                        
      other noncurrent assets
    		                   -1,240,000   0                         
      accounts payable
    		                   5,672,000 -182,000 -7,017,000 7,296,000 -1,220,000 -3,159,000 4,045,000          -1,706,000            
      accrued expenses and other current liabilities
    		                   -2,503,000 14,547,000 -3,634,000 -4,931,000 2,427,000                        
      income taxes payable
    		                   -25,051,000 15,859,000 6,654,000 -2,375,000 2,144,000 -14,559,000 4,856,000   327,000                   
      other liabilities
    		                   -758,000 -1,711,000 -1,020,000 -3,185,000                         
      loss on extinguishment of debt
    		                             91,000 103,000 101,000 0 0 382,000 25,000 241,000 2,134,000 860,000 39,000 1,693,000 0      
      change in fair value of derivative liability
    		                                    -1,000 49,000          
      deferred licensing revenue
    		                                -53,000 -52,000 300,000       623,000 -127,000 373,000    
      purchases of convertible note hedges
    		                                               
      conversion of convertible notes and interest make-whole
    		                             1,562,000 1,961,000 1,023,000 0 0 2,138,000 963,000 3,880,000 21,176,000          
      unsettled purchase of marketable securities included in accrued expenses
    		                                               
      property and equipment acquired under build-to-suit lease transaction
    		                                               
      interest capitalized during construction period for build-to-suit lease transaction
    		                                               
      facility lease financing obligation
    		                                               
      realized loss on sales of securities
    		                                               
      amortization of operating lease assets
    		                        351,000 879,000                      
      non-cash interest expense
    		                        1,414,000 1,437,000                      
      non-cash royalty revenue
    		                                               
      other non-current assets
    		                                               
      other non-current liabilities
    		                          -1,783,000 889,000 984,000 417,000     73,000    230,000   -13,000 434,000 44,000 125,000   
      cash paid for amounts included in the measurement of lease liabilities
    		                                               
      operating cash flows from operating leases
    		                        1,391,000 1,313,000                      
      non-cash investing and financing activities
    		                                               
      deferred legal fees included in accounts payable and accrued expenses
    		                        30,000 250,000 -200,000 176,000 304,000 -547,000 -4,700,000 6,584,000 2,383,000 1,758,000 3,779,000             
      non-cash interest expense on non-recourse liability related to sale of future royalties
    		                          1,191,000 1,204,000 701,000 155,000 160,000 959,000                
      accrued sales deductions
    		                          15,926,000 -2,990,000 4,691,000 12,151,000 4,171,000 1,507,000                
      accrued expenses
    		                          3,002,000          5,900,000 366,000          
      cash paid for interest
    		                             0   0   0   0   0 365,000 610,000    
      non-cash investing and financing activity:
    		                                               
      purchases of property, plant and equipment
    		                                               
      non-cash financial activity:
    		                                               
      net income
    		                             15,961,000 17,368,000 10,297,000 61,897,000 10,018,000 4,987,000 4,222,000 2,006,000 917,000 27,858,000 3,201,000 -15,543,000 -24,096,000 -27,357,000 -18,414,000 -13,483,000 -10,011,000 -9,277,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                               
      non-cash interest expense, net/interest (income)
    		                                               
      net increase in cash and cash equivalents
    		                                               
      cash and cash equivalents at beginning of period
    		                             0 0 66,398,000 -654,000 0 34,152,000 0 0 36,396,000 0 0 32,980,000 0 0 40,302,000 0 0 48,544,000 
      noncash financial activity:
    		                                               
      accrued income taxes payable
    		                              -67,000 1,668,000                
      unrealized loss on marketable securities
    		                                               
      non-cash interest expense on liability related to sale of future royalties
    		                                               
      accrued sales deduction
    		                                4,675,000 6,322,000 1,903,000             
      exercise of warrants
    		                                               
      non-cash interest expense, net/ interest income
    		                                               
      non cash interest expense, net/interest income
    		                                  155,000             
      unrealized (gain) loss on marketable securities
    		                                               
      deferred product revenue
    		                                        4,389,000 6,398,000 416,000 3,551,000    
      cash settlement of debt to equity conversion
    		                                               
      deferred legal fees included in accrued expenses
    		                                               
      adjustments to reconcile income from continuing operations to net cash from operating activities:
    		                                               
      unrealized gain on marketable securities
    		                                    -86,000 89,000  0 1,000     -2,000 8,000 
      adjustments to reconcile income to net cash from operating activities:
    		                                               
      change in fair value of derivative liabilities
    		                                         4,152,000      
      stock-based compensation expense
    		                                      704,000 652,000 667,000 491,000 432,000 337,000 130,000 53,000 52,000 
      interest receivable
    		                                         -192,000      
      accounts payable and accrued expenses
    		                                      2,939,000   2,998,000 1,103,000 238,000    
      capitalized patent defense costs
    		                                               
      proceeds from convertible debt issuance
    		                                         0      
      repayment of secured notes payable
    		                                         0      
      financing costs and underwriters discounts
    		                                         -29,000      
      conversion of convertible notes
    		                                      4,211,000 258,000 10,418,000       
      initial value of interest make-whole derivative issued in connection with the convertible debt
    		                                               
      initial value of conversion option reported in equity
    		                                               
      adjustments to reconcile loss to net cash from operating activities:
    		                                               
      initial value of interest make-whole derivative
    		                                               
      issued in connection with the convertible debt
    		                                         0      
      inventory
    		                                         -873,000      
      adjustments to reconcile loss to net cash used
    		                                               
      in operating activities:
    		                                               
      unrealized (loss) on marketable securities
    		                                               
      patent defense costs
    		                                               
      conversion of preferred stock
    		                                               
      initial value of conversion reported in equity
    		                                               
      change in fair value of warrant liability
    		                                            294,000 144,000 328,000 
      income from discontinued operations
    		                                               
      income from continuing operations
    		                                               
      gain on sale of property and equipment
    		                                               
      amortization of deferred financing costs
    		                                            84,000 81,000 83,000 
      interest payable
    		                                            -20,000 -12,000 133,000 
      deferred revenue
    		                                               
      net cash from operating activities from continuing operations
    		                                               
      net cash from operating activities from discontinued operations
    		                                               
      net cash from investing activities from continuing operations
    		                                               
      net cash from investing activities from discontinued operations
    		                                               
      proceeds from issuance of common stock, net of underwriters discounts
    		                                               
      proceeds from issuance of (payments on) secured notes payable
    		                                               
      financing costs
    		                                               
      net cash from financing activities from continuing operations
    		                                            -2,225,000   
      net cash from financing activities from discontinued operations
    		                                               
      cash paid for interest-continuing operations
    		                                               
      cash paid for interest-discontinued operations
    		                                               
      noncash conversion of preferred stock to common stock
    		                                            0   
      proceeds from issuance of common stock, net of offering costs
    		                                               
      proceeds from issuance of secured notes payable
    		                                               
      cash paid for interest—continuing operations
    		                                             800,000 688,000 
      cash paid for interest—discontinued operations
    		                                               
      deferred financing costs
    		                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.